Looks like our strains will have multiple uses over several multi billion dollar market products.
Just cheap and still buying.
From the quarterly:
"When compared to market leader, Aricept, which is currently used in the early management of Alzheimer’sDisease, the Dolce/NTI strains demonstrated 30% more potency than Aricept (and 80% more potency than CBD alone). Aricept currently has annual sales of over $1 billion USD and is the leading therapy in the early treatment of AD."
Cheers
Ann: Quarterly Report and Appendix 4C, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
